Stocks and Investing Stocks and Investing
Mon, October 9, 2023
Fri, October 6, 2023
Thu, October 5, 2023

Gregory Renza Reiterated (VIRX) at Buy and Held Target at $7 on, Oct 5th, 2023


Published on 2024-10-28 06:44:27 - WOPRAI, Gregory Renza
  Print publication without navigation


Gregory Renza of RBC Capital, Reiterated "Viracta Therapeutics, Inc." (VIRX) at Buy and Held Target at $7 on, Oct 5th, 2023.

Gregory has made no other calls on VIRX in the last 4 months.



There are 3 other peers that have a rating on VIRX. Out of the 3 peers that are also analyzing VIRX, 0 agree with Gregory's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Gregory


  • Andrew Berens of "SVB Securities" Maintained at Buy with Decreased Target to $5 on, Tuesday, August 15th, 2023
  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Tuesday, August 15th, 2023
  • Tony Butler of "EF Hutton" Initiated at Strong Buy and Held Target at $10 on, Monday, July 31st, 2023